PHOTOCODING
LIVE

Serial Number

97810807

Owner

Immunolight, LLC

Attorney

J. Derek Mason

Filing Date

Feb 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PHOTOCODING Trademark

Serial Number: 97810807

PHOTOCODING is a trademark filed by Immunolight, LLC on February 24, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 11 (Environmental Control), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Immunolight, LLC (27 trademarks)

c/o Bodman PLC
Detroit, MI 48226

Entity Type: 16

Trademark Details

Filing Date

February 24, 2023

Registration Date

Not Registered

Published for Opposition

September 3, 2024

Goods & Services

Pharmaceutical agents for treating conditions of living tissues by detecting and triggering biophoton and intercellular communication, and intracellular communication; preparations for sanitization and remediation of air supply, water supply, and biological materials for medical purposes; medical treatment and diagnostic kits comprising pharmaceutical agents for treating conditions of living tissues

Environmental control apparatus and system comprising energy converting chemical powders and particles for the sanitization and remediation of air supply, water supply and biological materials

Medical services for treating a medical condition by detection of biophotons, intercellular communication, or intracellular communication; medical services for treating a medical condition by detection and propagation of biophotons, intercellular communication, or intracellular communication; medical services for treating a medical condition by triggering of biophotons, intercellular communication, or intracellular communication

Environmental control apparatus and system comprising energy converters featuring energy converting chemical powders and particles for the sanitization and remediation of air supply, water supply, or biological materials

Medical device for detection of biophotons, intercellular communication, and intracellular communication; medical device for treating a medical condition by detection of biophotons, intercellular communication, and intracellular communication; medical device for triggering of biophotons, intercellular communication, and intracellular communication; medical device for treating a medical condition by triggering of biophotons, intercellular communication, and intracellular communication

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 18, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 17, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 17, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 25, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 24, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 24, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 24, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 16, 2024 GNFN
FINAL REFUSAL E-MAILED
May 16, 2024 GNFR
FINAL REFUSAL WRITTEN
May 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 30, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 30, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2023 NWOS
NEW APPLICATION ENTERED
Feb 28, 2023 NWAP